Search

everythinglearnresearchcommunity

for

Search:↓

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

A patient with a larger than usual genetic mutation had a broader range of symptoms for a muscle disease.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

The document reports the first Brazilian case of a girl with Becker nevus syndrome, characterized by skin changes, breast underdevelopment, and scoliosis.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Finasteride may cause kidney damage.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Increased PPARGC1α relates to hair thinning in common baldness.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

New treatments for hair loss are being developed using molecular biology.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Review finds no permanent solution for female hair loss.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.